-
Mashup Score: 3
Scott Kopetz, MD, PhD, FACP, highlights the efficacy of encorafenib/cetuximab with mFOLFOX6 in BRAF V600E–mutated metastatic colorectal cancer.
Source: www.onclive.comCategories: General Medicine NewsTweet
-
Mashup Score: 0I Am Living With Recurring Stage IV Colorectal Cancer - 11 month(s) ago
Despite urgings from my primary care physician to get a colonoscopy screening after I turned 50, I resisted. As a health-care provider, and someone who is tuned into changes in my body, I thought I would instinctively know if I had a serious illness. I was wrong. Even after finally relenting to at least take an at-home stool-based colon cancer test, in early January 2019, which found a positive result, I still believed I was in excellent health and the result was a false-positive. I had no symptoms of
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet-
I Am Living With Recurring Stage IV Colorectal Cancer, by Brian Beck https://t.co/bXuCBZ7B8l #crcsm #colorectalcancer
-
-
Mashup Score: 0
In a nationwide Danish cohort study reported in JAMA Oncology, Nors et al found the 5-year risk of recurrence after surgery for stage I to III colorectal cancer decreased over time and the time to recurrence was shorter with a more advanced disease stage. The study used the Danish Colorectal Cancer Group Database to identify patients with stage I to III colorectal cancer who underwent primary surgery between January 2004 and December 2019. Stage-specifi c 5-year recurrence—reported as the cumulative
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet-
Colorectal Cancer: Incidence and Time to Recurrence https://t.co/jlyrtaWSOm #crcsm #colorectalcancer
-
-
Mashup Score: 0Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC - 1 year(s) ago
Patrick Boland, MD, discusses the development of therapeutic strategies targeting KRAS G12C mutations in colorectal cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
WATCH: Patrick Boland, MD, discusses the development of therapeutic strategies targeting KRAS G12C mutations in colorectal cancer. #crcsm #ColorectalCancer https://t.co/gz6YNE6btB
-
-
Mashup Score: 35
I’ve been contending with health issues since I was 12, when I was diagnosed with Crohn’s disease. As I began my early 30s, I was feeling the healthiest of my life. I was working out 5 days a week and attributed sudden weight loss and fatigue to weight training and high-intensity Zumba classes. The one concerning symptom was a feeling of food getting stuck in my digestive system every time I ate, and I began having unrelenting heartburn as well as abdominal and chest pain. Since my Crohn’s disease
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet-
Having Colorectal Cancer at 32 Changed the Trajectory of My Life, by Allison Rosen, MS https://t.co/uoV8bhCLYM #crcsm #colorectalcancer @ARosen380
-
-
Mashup Score: 35
I’ve been contending with health issues since I was 12, when I was diagnosed with Crohn’s disease. As I began my early 30s, I was feeling the healthiest of my life. I was working out 5 days a week and attributed sudden weight loss and fatigue to weight training and high-intensity Zumba classes. The one concerning symptom was a feeling of food getting stuck in my digestive system every time I ate, and I began having unrelenting heartburn as well as abdominal and chest pain. Since my Crohn’s disease
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet-
Having Colorectal Cancer at 32 Changed the Trajectory of My Life, by Allison Rosen, MS https://t.co/uoV8bhCLYM #crcsm #colorectalcancer @ARosen380
-
Following its @US_FDA approval in December 2024, the combination of encorafenib/cetuximab plus mFOLFOX6 has emerged as a new mainstay treatment for patients with BRAF V600E–mutated mCRC. @skopetz #crcsm #ColorectalCancer https://t.co/c9zNyUUb4a